Introduction to ACCORD-PMI: The Advisory Council on Care Optimization to Reduce Death Post-MI

      In 2002, the number of patients discharged from US hospitals after an acute coronary syndrome (ACS) was estimated conservatively at 942,000. About 85% of these patients had a myocardial infarction (MI) and the remaining 15% experienced unstable angina without MI.
      Heart Disease and Stroke Statistics—2005 Update.
      When secondary discharge diagnoses are included, the corresponding number of hospital discharges that year for ACS was approximately 1.7 million: 973,000 for MI and 728,000 for unstable angina.
      Heart Disease and Stroke Statistics—2005 Update.
      The percentage of patients with ACS who have ST-segment elevation MI is estimated at 30%–45%.
      Heart Disease and Stroke Statistics—2005 Update.
      First-time MIs account for approximately 65% of all events and the average age at the time of MI is 65.8 years for men and 70.4 years for women.
      Heart Disease and Stroke Statistics—2005 Update.
      The above numbers call attention to the prevalence of MI in the United States and the need for action to be taken to provide these patients with optimal medical care.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Heart Disease and Stroke Statistics—2005 Update.
        American Heart Association, Dallas, Texas2004
        • Wu A.H.
        • Parsons L.
        • Every N.R.
        • Bates E.R.
        Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
        J Am Coll Cardiol. 2002; 40: 1389-1394
        • Velazquez E.J.
        • Francis G.S.
        • Armstrong P.W.
        • Aylward P.E.
        • Diaz R.
        • O'Connor C.M.
        • White H.D.
        • Henis M.
        • Rittenhouse L.M.
        • Kilaru R.
        • et al.
        An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
        Eur Heart J. 2004; 25: 1911-1919
        • Lanza G.A.
        • Guido V.
        • Galeazzi M.M.
        • Mustilli M.
        • Natali R.
        • Ierardi C.
        • Milici C.
        • Burzotta F.
        • Pasceri V.
        • Tomassini F.
        • Lupi A.
        • Maseri A.
        Prognostic role of heart rate variability in patients with a recent acute myocardial infarction.
        Am J Cardiol. 1998; 82: 1323-1328
        • Jong P.
        • Vowinckel E.
        • Liu P.P.
        • Gong Y.
        • Tu J.V.
        Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study.
        Arch Intern Med. 2002; 162: 1689-1694
        • Krumholz H.M.
        • Amatruda J.
        • Smith G.L.
        • Mattera J.A.
        • Roumanis S.A.
        • Radford M.J.
        • Crombie P.
        • Vaccarino V.
        Randomized trial of an education and support intervention to prevent readmission of patients with heart failure.
        J Am Coll Cardiol. 2002; 39: 83-89
        • Gheorghiade M.
        • Zannad F.
        • Sopko G.
        • Klein L.
        • Piña I.L.
        • Konstam M.A.
        • Massie B.M.
        • Roland E.
        • Targum S.
        • Collins S.P.
        • Filippatos G.
        • Tavazzi L.
        Acute heart failure syndromes: current state and framework for future research.
        Circulation. 2005; 112: 3958-3968
        • Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF)
        Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
        JAMA. 2002; 287: 1531-1540
        • Felker G.M.
        • Benza R.L.
        • Chandler A.B.
        • Leimberger J.D.
        • Cuffe M.S.
        • Califf R.M.
        • Gheorghiade M.
        • O'Connor C.M.
        Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
        J Am Coll Cardiol. 2003; 41: 997-1003
        • Levy D.
        • Larson M.G.
        • Vasan R.S.
        • Kannel W.B.
        • Ho K.K.
        The progression from hypertension to congestive heart failure.
        JAMA. 1996; 275: 1557-1562
        • Buxton A.E.
        Sudden death after myocardial infarction—who needs prophylaxis, and when?.
        N Engl J Med. 2005; 352: 2638-2640
        • MERIT-HF Study Group
        Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
        Lancet. 1999; 353: 2001-2007
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • Poole J.E.
        • Packer D.L.
        • Boineau R.
        • Domanski M.
        • Troutman C.
        • Anderson J.
        • Johnson G.
        • et al.
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Solomon S.D.
        • Zelenkofske S.
        • McMurray J.J.
        • Finn P.V.
        • Velazquez E.
        • Ertl G.
        • Harsanyi A.
        • Rouleau J.L.
        • Maggioni A.
        • Kober L.
        • et al.
        Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
        N Engl J Med. 2005; 352: 2581-2588
        • St John Sutton M.
        • Pfeffer M.A.
        • Plappert T.
        • Rouleau J.L.
        • Moye L.A.
        • Dagenais G.R.
        • Lamas G.A.
        • Klein M.
        • Sussex B.
        • Goldman S.
        • et al.
        Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril.
        Circulation. 1994; 89: 68-75
        • Patten R.D.
        • Soman P.
        Prevention and reversal of LV remodeling with neurohormonal inhibitors.
        Curr Treat Options Cardiovasc Med. 2004; 6: 313-325
        • Spencer F.A.
        • Meyer T.E.
        • Gore J.M.
        • Goldberg R.J.
        Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction.
        Circulation. 2002; 105: 2605-2610
        • Barzilai B.
        • Gessler Jr, C.
        • Perez J.E.
        • Schaab C.
        • Jaffe A.S.
        Significance of Doppler-detected mitral regurgitation in acute myocardial infarction.
        Am J Cardiol. 1988; 61: 220-223
        • Lamas G.A.
        • Mitchell G.F.
        • Flaker G.C.
        • Smith Jr, S.C.
        • Gersh B.J.
        • Basta L.
        • Moye L.
        • Braunwald E.
        • Pfeffer M.A.
        Clinical significance of mitral regurgitation after acute myocardial infarction.
        Circulation. 1997; 96: 827-833
        • Tcheng J.E.
        • Jackman Jr, J.D.
        • Nelson C.L.
        • Gardner L.H.
        • Smith L.R.
        • Rankin J.S.
        • Califf R.M.
        • Stack R.S.
        Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction.
        Ann Intern Med. 1992; 117: 18-24
        • Lehmann K.G.
        • Francis C.K.
        • Dodge H.T.
        Mitral regurgitation in early myocardial infarction: incidence, clinical detection, and prognostic implications.
        Ann Intern Med. 1992; 117: 10-17
        • Morgan S.
        • Smith H.
        • Simpson I.
        • Liddiard G.S.
        • Raphael H.
        • Pickering R.M.
        • Mant D.
        Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.
        BMJ. 1999; 318: 368-372
        • Gheorghiade M.
        • Teerlink J.R.
        • Mebazaa A.
        Pharmacology of new agents for acute heart failure syndromes.
        Am J Cardiol. 2005; 96: 68G-73G
        • Gheorghiade M.
        • Bonow R.O.
        Chronic heart failure in the United States: a manifestation of coronary artery disease.
        Circulation. 1998; 97: 282-289
        • Gheorghiade M.
        • Abraham W.T.
        • Albert N.M.
        • Greenberg B.H.
        • O'Connor C.M.
        • She L.
        • Stough W.G.
        • Yancy C.W.
        • Young J.B.
        • Fonarow G.C.
        Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
        JAMA. 2006; 296: 2217-2226